This PR re-compiles figures that needed recompiling. I found a few other sneaky axes to update "sample" -> "tumor" that were previously missed. There are now PDFs and PNGs of new compilations. Here's the rundown (hopefully roughly complete...) of why each of these compilations changed, figure-by-figure:
Figure 1
Panel B y-axis is updated to say "tumors"
Panel B now reads "Ependymoma" and not "Ependymal tumor"
Figure 2
All oncoprints changed with V23 independent samples
Embryonal legend was reordered
Figure 3
Panels A/B changed with V23 independent samples
The panel A y-axis needed a "sample" -> "tumor" update, so I updated the interaction-plots code, regenerated figures, and copied over the new figure panel to figures/pdfs/.
Panel C regression changed with V23 independent samples
Panel D changed with V23 independent samples
Panel E samples -> tumor change
Figure 4
Panels G and H (2 of the survival models) had slight changes in V23
Figure 5
UMAP legend now reads "Ependymoma" and not "Ependymal tumor"
I replaced the GSEA heatmap with new V23 version, since it's a heatmap and who really knows about diffs.
Panels C and E sample -> tumor change
Figure S4
Panel A sample -> tumor
Figure S6
EPN panel title now reads "Ependymoma" and not "Ependymal tumor"
Panel E and F sample -> tumor change
Note that Panel F was re-generated in #1682 but I missed adding the new PDF! It's added here.
Worth noting that other compilations were updated previously:
Closes #1676
This PR re-compiles figures that needed recompiling. I found a few other sneaky axes to update "sample" -> "tumor" that were previously missed. There are now PDFs and PNGs of new compilations. Here's the rundown (hopefully roughly complete...) of why each of these compilations changed, figure-by-figure:
interaction-plots
code, regenerated figures, and copied over the new figure panel tofigures/pdfs/
.Worth noting that other compilations were updated previously:
Also worth noting that this PR does not do the tumor purity supp figure described in #1665. That will happen in its own PR.
Reviewers please let me know if/where I can clarify inventory here!